Literature DB >> 15249628

Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study.

M J Edwards1, E Trikouli, D Martino, M Bozi, R C Dale, A J Church, A Schrag, A J Lees, N P Quinn, G Giovannoni, K P Bhatia.   

Abstract

Anti-basal ganglia antibodies (ABGA) are associated with movement disorders in children, but have not been assessed in adult onset movement disorders. In a prospective assessment ABGA were positive in 65% of a group of 65 patients with atypical movement disorders, but were very rare in healthy adults and adults with idiopathic dystonia. An autoimmune mechanism may underlie a proportion of cases of atypical movement disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249628     DOI: 10.1212/01.wnl.0000131900.71337.c7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

Review 1.  Post infectious CNS disorders: towards a unified approach.

Authors:  Marc Gotkine; Peter G E Kennedy; Israel Steiner
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

2.  Immunity and behavior: antibodies alter emotion.

Authors:  Patricio T Huerta; Czeslawa Kowal; Lorraine A DeGiorgio; Bruce T Volpe; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-04       Impact factor: 11.205

3.  Streptococcal infection, Tourette syndrome, and OCD: is there a connection?

Authors:  A Schrag; R Gilbert; G Giovannoni; M M Robertson; C Metcalfe; Y Ben-Shlomo
Journal:  Neurology       Date:  2009-09-30       Impact factor: 9.910

Review 4.  How Much Do We Know about Adult-onset Primary Tics? Prevalence, Epidemiology, and Clinical Features.

Authors:  Daphne Robakis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-05-17

5.  Ischemic stroke and epilepsy in a patient with Tourette's syndrome: association with the antiphospholipid syndrome and good response to levetiracetam.

Authors:  M Seijo-Martínez; J A Mosquera-Martínez; S Romero-Yuste; J Cruz-Martinez
Journal:  Open Neurol J       Date:  2008-06-12

Review 6.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.